News
Eye care company Alcon Inc., which has a major presence in North Texas, plans to buy Lensar Inc. in a deal valued up to $430 million. Orlando-based Lensar (Nasdaq: LNSR) is a laser cataract ...
PRECISION7, a reusable one-week replacement contact lens, has been widely launched in the U.S. This product targets a $3.8 billion market segment where Alcon is under-indexed. Early feedback ...
1mon
Zacks.com on MSNIs it the Right Time to Hold Alcon Stock in Your Portfolio Now?In contact lenses, the company is successfully executing its strategy of investing in fast-growing market segments where it ...
For this study, the research team recruited 48 current contact lens wearers who had no underlying ocular disease or dry eye symptoms, and who were generally happy with their current lenses. The test ...
Alcon operates in two segments: vision care and surgical. Vision care made up 43% of fiscal 2023 total sales and comprises contact lenses and ocular health products. The U.S. contact lens market ...
Alcon manufactures contact lenses as well as equipment for eye surgery. In 2024, its revenues totaled $9.8 billion, a 5% rise year-on-year.
Alcon’s shares made their debut on the SIX Swiss Exchange this morning and rose quickly, with early trading valuing the now-independent specialist in contact lenses and other eye care devices at ...
Terms of the deal weren't disclosed. Aurion will operate as a separate company from Alcon, whose products include contact lenses and eye drops. The deal will also see Arnaud Lacoste, who most ...
GENEVA, April 02, 2025--Alcon Expands Leadership in IOL Innovation ... the first and only monthly replacement Water Gradient toric contact lens,1-3 delivering the same exceptionally comfortable ...
Polyquad was formulated in the mid 1980s by Alcon as a preservative for contact lens storage solutions. It was developed because other preservatives (e.g., BAK) were known to become concentrated ...
Alcon acquired a majority interest in Aurion Biotech, a clinical-stage company developing advanced cell therapies to treat eye diseases. Terms of the deal weren't disclosed. Aurion will operate as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results